Reference:Adams IB:Ryan W:Singer M:Thomas BF:Compton DR:Razdan RK:Martin BR:,J. Pharmacol. Exp. Ther.,1995,273,1172: Difference between revisions

No edit summary
 
No edit summary
Line 5: Line 5:
&&n.a.&&LBF20806SF01
&&n.a.&&LBF20806SF01
&&n.a.&&LBF20806SF02
&&n.a.&&LBF20806SF02
&&n.a.&&LBF20506AM01
&&n.a.&&LBF20806SF03
&&n.a.&&LBF20806SF03
&&n.a.&&LBF20806AM02
&&n.a.&&LBF20806AM02
&&n.a.&&LBF20406AM40
&&n.a.&&LBF20406AM40
&&n.a.&&LBF20406AM41
|pubmed=7791088
|pubmed=7791088
|title=Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs
|title=Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs
|doi=
|doi=
}}
}}

Revision as of 04:15, 10 June 2010

Details

If you newly created/edited a reference page, please click all authors' links to check their information.

TITLE "Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs"
Title Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs
Author(s)
 
 
 
 
 
 
     (Click a name to see records for each author.)
Journal Journal of Pharmacology and Experimental Therapeutics     
(6 pages)
Year 1995
Volume 273
Page 1172



Metabolite information in this article

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20000AM01 N-Eicosanoylethanolamine This page
n.a. LBF20000AM02 N-Eicosanoyl-(2'-fluoroethyl)amine This page
n.a. LBF20806SF01 This page
n.a. LBF20806SF02 This page
n.a. LBF20806SF03 This page
n.a. LBF20806AM02 This page
n.a. LBF20406AM40 N- 2-Fluoroethylarachidonoylamide This page
n.a. LBF20406AM41 Arachidonoylmorpholine This page